Skip to content

Resistance Exercise and Cognition in People With Type 1 Diabetes

The Effects of Resistance Exercise on Cognition in People With Type 1 Diabetes: a Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05963152
Enrollment
54
Registered
2023-07-27
Start date
2023-07-20
Completion date
2024-08-01
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type1diabetes

Keywords

exercise, cognition

Brief summary

The aim of the current study is to determine the effects of resistance exercise on performance of the Paced Auditory Serial Addition Test and the Colour Trails Test.

Interventions

Participants will be asked to maintain their normal activity levels

Between 6-10am participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)

Between 4-8pm participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)

Sponsors

Dasman Diabetes Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

1:1:1 parallel group design

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Physician confirmed type 1 diabetes for at least 1 year * Stable insulin therapy for 3 months prior to the study

Exclusion criteria

* BMI of 45 or higher * BP of 160/100mmHg or higher * autonomic neuropathy * severe proliferative retinopathy * joint or limb injuries preventing weight-bearing activity * autonomic neuropathy * severe proliferative retinopathy * any other medical condition that prevents participants from exercising safely.

Design outcomes

Primary

MeasureTime frameDescription
Chronic change in Paced Auditory Serial Addition Test (PASAT) scoreChange from baseline to 12 weeksMeasured using the standardised Paced Auditory Serial Addition Test (PASAT) score ranging from 0-60 with a higher score meaning a better outcome
Chronic change in Colour Trails Test scoreChange from baseline to 12 weeksMeasured using the standardised Colour Trails Test, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome

Secondary

MeasureTime frameDescription
Baseline acute change in Paced Auditory Serial Addition Test (PASAT) scoreChange from before (0 hour) to 1 hour post exercise during week 1Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the first exercise session, score ranging from 0-60 with a higher score meaning a better outcome
12 week acute change in Paced Auditory Serial Addition Test (PASAT) scoreChange from before (0 hour) to 1 hour post exercise during week 12Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the last exercise session, score ranging from 0-60 with a higher score meaning a better outcome
Baseline acute change in Colour Trails Test scoreChange from before (0 hour) to 1 hour post exercise during week 1Measured using the standardised Colour Trails Test during the first exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome
12 week acute change in Colour Trails Test scoreChange from before (0 hour) to 1 hour post exercise during week 12Measured using the standardised Colour Trails Test during the last exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome

Countries

Kuwait

Contacts

Primary ContactEbaa AlOzairi
ebaa.alozairi@dasmaninstitute.rog+965 22242999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026